[Federal Register Volume 71, Number 149 (Thursday, August 3, 2006)]
[Notices]
[Page 44035]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E6-12569]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


National Mammography Quality Assurance Advisory Committee; Notice 
of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committee: National Mammography Quality Assurance Advisory 
Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on September 28, 2006, from 
10 a.m. to 6 p.m., and on September 29, 2006, from 8 a.m. to 1 p.m.
    Location: Atrium Court Hotel, Remington 1 and 2, Three Research 
Ct., Rockville, MD.
    Contact Person: Nancy Wynne, Center for Devices and Radiological 
Health (HFZ-240), Food and Drug Administration, 1350 Piccard Dr., 
Rockville, MD 20850, 240-276-3284, or FDA Advisory Committee 
Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC 
area), code 3014512397. Please call the Information Line for up-to-date 
information on this meeting.
    Agenda: The committee will discuss: (1) Amendments to the current 
regulations, and (2) all guidance documents issued since the last 
meeting. The committee will also receive updates on recently approved 
alternative standards and the radiological health program. MQSA 
regulations and guidance documents are available to the public on the 
Internet at http://www.fda.gov/cdrh/mammography.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person on or before 
August 29, 2006. Oral presentations from the public will be scheduled 
between approximately 10:30 a.m. and 11:30 a.m. on September 28, 2006, 
and between approximately 8:30 a.m. and 9:30 a.m. on September 29, 
2006. Time allotted for each presentation may be limited. Those 
desiring to make formal oral presentations should notify the contact 
person and submit a brief statement of the general nature of the 
evidence or arguments they wish to present, the names and addresses of 
proposed participants, and an indication of the approximate time 
requested to make their presentation on or before August 29, 2006.
    Persons attending FDA's advisory committee meetings are advised 
that the agency is not responsible for providing access to electrical 
outlets.
    FDA welcomes the attendance of the public at its advisory committee 
meetings and will make every effort to accommodate persons with 
physical disabilities or special needs. If you require special 
accommodations due to a disability, please contact Shirley Meeks, 
Conference Management Staff, at 301-827-7292, at least 7 days in 
advance of the meeting.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: July 27, 2006.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E6-12569 Filed 8-2-06; 8:45 am]
BILLING CODE 4160-01-S